Treatment | Body Weight Loss Mean (±S.E.M.) | Body Weight Recovery Mean (±S.E.M.) | ||
---|---|---|---|---|
24 h Post | 48 h Post | |||
g | ||||
Control | -5.35 (0.13) | 5.32 (0.16) | 5.78 (0.19) | |
Systemic naltrexone, s.c. | ||||
0.1 mg/kg | -5.18 (0.24) | 5.14 (0.53) | 5.62 (0.53) | |
1.0 mg/kg | -4.28 (0.19) | 3.82 (0.36)* | 2.24 (1.79)* | |
5.0 mg/kg | -5.13 (0.53) | 5.27 (0.54) | 5.81 (0.48) | |
Central naltrexone, i.c.v. | ||||
10 μg | -4.67 (0.75) | -0.89 (0.62)* | -1.05 (1.14)* | |
50 μg | -5.77 (0.23) | 4.66 (0.31)* | 5.87 (0.29) | |
βFNA | ||||
5 μg | -5.58 (0.43) | 2.89 (0.80)* | 3.99 (0.47)* | |
20 μg | -6.57 (0.31) | 6.06 (0.48) | 6.31 (0.62) | |
NBNI | ||||
5 μg | -4.57 (0.27) | 2.53 (0.70)* | 2.73 (1.20)* | |
20 μg | -4.84 (0.60) | 3.52 (0.64)* | 4.23 (0.88)* | |
NTI | ||||
5 μg | -4.91 (0.28) | 3.70 (0.41)* | 5.28 (0.39) | |
20 μg | -3.73 (0.72) | 4.00 (0.84)* | 3.42 (3.33)* |
↵* Significant reduction relative to corresponding control value